CDP Venture Capital's Biotechnology Portfolio

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

Developing analytical systems to characterize next-generation cancer immunotherapy

Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products

IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Arsenale is an innovative end-to-end bio-manufacturing platform integrating hardware, data, and AI to produce at scale.

Sustainable, high performance aquaculture feeds

ExoLab Italia is a biotechnological company that provides research, development and production of products.

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases

Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

GI develops super-resolution optical microscopes, empowering researchers to explore the microscopic world with unprecedented detail.

Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology.

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

MOGU is a European company, based in Italy, developing a range of mycelium-based technologies.

Morphocell Technologies is a regenerative medicine company.

Neuron Guard is developing a medical device the new standard of care for targeted temperature management of brain damages.

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

SQIM is a biotechnological based agency.

Wood-derived bone implants for patients with bone fractures.

Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.